White Papers / Tech Papers

Structural Characterization of Biologics Using High-Resolution Mass Spectrometry

High-resolution mass spectrometry is a key component in the characterization of novel biologics and biosimilars.

Company Logo

Released By Alcami Corporation

Biopharmaceutical products represent up to 20 percent of the total pharmaceutical market and are growing at a rate of nearly eight percent annually. To keep up with this impressive growth rate, many contract development and manufacturing organizations (CDMOs) are making strategic investments in equipment and expertise to support analytical development and structural characterization of biopharmaceuticals in more economical and efficient ways.
 
DOWNLOAD TO LEARN MORE>>>>

Download White Papers / Tech Papers Now

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters